Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
暂无分享,去创建一个
J. Rosenstock | L. Blonde | J. Buse | G. Sesti | M. Zychma | E. Montanya | W. Schmidt | J. Brett